New dengue drug trial aims to shorten illness and lower virus levels
Disease control
Recruiting now
This study tests a new medicine called CP-COV03 in adults with dengue fever. The goal is to see if it can safely lower the amount of virus in the blood and help people feel better faster. About 210 participants will receive either the drug or a placebo. The trial is currently rec…
Phase: PHASE2, PHASE3 • Sponsor: Hyundai Bioscience Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC